RNAC logo
Cartesian Therapeutics, Inc.(RNAC)
Last print unknown agoAbout this dataData status
$6.08▼-0.19 (-3.03%)Stale · unknown old

RNAC Net Income Growth

-324.54%TTM

Period ending:

RNAC TTM Net Income YoY %%
RNAC TTM Net Income YoY %457.32%-1811.73%
2016-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

RNAC net income growth history

Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 39 observations from Dec 31, 2016 to Jun 30, 2026.

Cartesian Therapeutics Inc Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
-324.545%
-296.1733%
-68.2967%
80.4031%
84.2106%
84.9689%
64.7608%
-577.0901%
-555.2011%
-1,592.1458%
-721.0181%
-186.6603%
-210.4842%
-154.399%
237.7311%
178.1777%
170.175%
137.4907%
62.7054%
21.8771%
35.952%
-17.4208%
-24.4372%
-23.9599%
-19.3894%
-2.2333%
15.2841%
21.5239%
14.1995%
6.8907%
-0.023%
-17.3221%
-30.2238%
-50.6223%
-80.3949%
-106.5848%
-96.1665%
-62.9751%
-43.8389%

Compare net income growth

Other companies in Health Care. Each page shows its own reporting periods and currency.

Compare all covered stocks by net income growth →

All RNAC financial metrics · RNAC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.